open access

Vol 7 (2022): Continuous Publishing
Original paper
Published online: 2022-11-16
Get Citation

Use of SD-OCT to quantitatively evaluate peripheral congestion in diastolic dysfunction with a role model in hemodialysis patients with end-stage renal disease.

Ibrahim Ozdemir1, Süleyman Çağan Efe2
·
Ophthalmol J 2022;7:194-199.
Affiliations
  1. Department of Ophthalmology, Dünyagöz Hospital, Sakarya, Türkiye
  2. Department of Cardiology, Kartal Research and Training Hospital, İstanbul, Turkey

open access

Vol 7 (2022): Continuous Publishing
ORIGINAL PAPERS
Published online: 2022-11-16

Abstract

Background: There is no practical quantitative tool to assess peripheral congestion in patients with congestive heart failure. In this study, we aimed to evaluate peripheral congestion by measuring the choroidal thickness with SD-OCT in patients with end-stage renal disease (ESRD). In addition, volume management by hemodialysis (HD) is often difficult in patients with ESRD. Volume overload or hypovolemia may increase morbidity and mortality in long-term HD patients. Therefore, it is important to determine the ideal ultrafiltration rate (UFR) for each patient. Also, we aimed to find data to help determine the ideal UFR.

Material and methods: Fifty HD patients with ESRD were divided into 3 groups according to diastolic functions. Patients with mild diastolic dysfunction were enrolled in Group1, those with moderate diastolic dysfunction were enrolled in Group 2, and those with severe diastolic dysfunction were enrolled in Group 3. The choroid was used to evaluate peripheral congestion, and choroidal thickness (CT) was measured by optical coherence tomography (OCT) before and after HD.

Results: The average CT before HD in Group 3 (259.3 ± 7.5 μm ) was significantly higher than in Group 1 (249.6 ± 9.4 μm) (p = 0.015). The average CT after HD in Group 3 (224.1 ± 5.2 μm ) was significantly higher than in Group 1 (232.4 ± 9.3 μm) (p = 0.033). The mean of DCT was significantly higher in Group 3 than in Group 1 (p < 0.001).

Conclusion: DCT was correlated with diastolic function in ESRD patients undergoing HD, and further evaluation of diastolic function before HD may play a role in finding the ideal UFR.

Abstract

Background: There is no practical quantitative tool to assess peripheral congestion in patients with congestive heart failure. In this study, we aimed to evaluate peripheral congestion by measuring the choroidal thickness with SD-OCT in patients with end-stage renal disease (ESRD). In addition, volume management by hemodialysis (HD) is often difficult in patients with ESRD. Volume overload or hypovolemia may increase morbidity and mortality in long-term HD patients. Therefore, it is important to determine the ideal ultrafiltration rate (UFR) for each patient. Also, we aimed to find data to help determine the ideal UFR.

Material and methods: Fifty HD patients with ESRD were divided into 3 groups according to diastolic functions. Patients with mild diastolic dysfunction were enrolled in Group1, those with moderate diastolic dysfunction were enrolled in Group 2, and those with severe diastolic dysfunction were enrolled in Group 3. The choroid was used to evaluate peripheral congestion, and choroidal thickness (CT) was measured by optical coherence tomography (OCT) before and after HD.

Results: The average CT before HD in Group 3 (259.3 ± 7.5 μm ) was significantly higher than in Group 1 (249.6 ± 9.4 μm) (p = 0.015). The average CT after HD in Group 3 (224.1 ± 5.2 μm ) was significantly higher than in Group 1 (232.4 ± 9.3 μm) (p = 0.033). The mean of DCT was significantly higher in Group 3 than in Group 1 (p < 0.001).

Conclusion: DCT was correlated with diastolic function in ESRD patients undergoing HD, and further evaluation of diastolic function before HD may play a role in finding the ideal UFR.

Get Citation

Keywords

end-stage renal disease; diastolic dysfunction; choroidal thickness; ultrafiltration rate

About this article
Title

Use of SD-OCT to quantitatively evaluate peripheral congestion in diastolic dysfunction with a role model in hemodialysis patients with end-stage renal disease.

Journal

Ophthalmology Journal

Issue

Vol 7 (2022): Continuous Publishing

Article type

Original paper

Pages

194-199

Published online

2022-11-16

Page views

3503

Article views/downloads

269

DOI

10.5603/OJ.2022.0029

Bibliographic record

Ophthalmol J 2022;7:194-199.

Keywords

end-stage renal disease
diastolic dysfunction
choroidal thickness
ultrafiltration rate

Authors

Ibrahim Ozdemir
Süleyman Çağan Efe

References (18)
  1. Leypoldt JK, Cheung AK, Delmez JA, et al. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002; 61(1): 266–275.
  2. Chou JA, Kalantar-Zadeh K. Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient. Curr Heart Fail Rep. 2017; 14(5): 421–427.
  3. Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res. 2000; 32(6): 249–256.
  4. Shin YUn, Lee SE, Kang MHo, et al. Evaluation of changes in choroidal thickness and the choroidal vascularity index after hemodialysis in patients with end-stage renal disease by using swept-source optical coherence tomography. Medicine (Baltimore). 2019; 98(18): e15421.
  5. Gök M, Karabas VL, Emre E, et al. Evaluation of choroidal thickness via enhanced depth-imaging optical coherence tomography in patients with systemic hypertension. Indian J Ophthalmol. 2015; 63(3): 239–243.
  6. Altinkaynak H, Kara N, Sayın N, et al. Subfoveal choroidal thickness in patients with chronic heart failure analyzed by spectral-domain optical coherence tomography. Curr Eye Res. 2014; 39(11): 1123–1128.
  7. Smyth B, Chan C, Grieve S, et al. Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis. J Cardiac Fail. 2020; 26(6): 482–491.
  8. Jung JiW, Chin HS, Lee DH, et al. Changes in subfoveal choroidal thickness and choroidal extravascular density by spectral domain optical coherence tomography after haemodialysis: a pilot study. Br J Ophthalmol. 2014; 98(2): 207–212.
  9. Ishibazawa A, Nagaoka T, Minami Y, et al. Choroidal Thickness Evaluation Before and After Hemodialysis in Patients With and Without Diabetes. Invest Ophthalmol Vis Sci. 2015; 56(11): 6534–6541.
  10. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29(4): 277–314.
  11. Alm A, Bill A. Ocular Circulation. 9th ed. Mosby, St Louis 1992.
  12. Schuster AK, Leuschner A, Feretos C, et al. Choroidal thickness is associated with cardiovascular risk factors and cardiac health: the Gutenberg Health Study. Clin Res Cardiol. 2020; 109(2): 172–182.
  13. Mansouri K, Medeiros FA, Marchase N, et al. Assessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomography. Ophthalmology. 2013; 120(12): 2508–2516.
  14. Ikuno Y, Maruko I, Yasuno Y, et al. Reproducibility of retinal and choroidal thickness measurements in enhanced depth imaging and high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci. 2011; 52(8): 5536–5540.
  15. Malik J, Kudlicka J, Valerianova A, et al. Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines. Int J Cardiovasc Imaging. 2019; 35(2): 313–317.
  16. Antlanger M, Aschauer S, Kopecky C, et al. Heart failure with preserved and reduced ejection fraction in hemodialysis patients: prevalence, disease pre- diction and prognosis. Kidney Blood Press Res. 2017; 42(1): 165–176.
  17. Cause of hypoxemia during hemodialysis. N Engl J Med. 1981; 305(22): 1351–1352.
  18. Park J, Rhee CM, Sim JJ, et al. A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int. 2013; 84(4): 795–802.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Publisher: VM Media Group sp. z o.o., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 310 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl